Dr Tanya Parkinson, 15 June 1965–8 August 2016
Antimicrobials and QT prolongation
DNA replication proteins as potential targets for antimicrobials in drug-resistant bacterial pathogens
Re-emergence of methicillin susceptibility in a resistant lineage of Staphylococcus aureus
Environmental emission of multiresistant Escherichia coli carrying the colistin resistance gene mcr-1 from German swine farms
Impact of plasmid-borne oqxAB on the development of fluoroquinolone resistance and bacterial fitness in Escherichia coli
Molecular insights into fosfomycin resistance in Escherichia coli
Chromosomally encoded ESBL genes in Escherichia coli of ST38 from Mongolian wild birds
Antibiotic susceptibility and molecular analysis of invasive Haemophilus influenzae in Canada, 2007 to 2014
Diversity and functionality of plasmid-borne VagCD toxin–antitoxin systems of Klebsiella pneumoniae
Macrolide resistance in Legionella pneumophila : the role of LpeAB efflux pump
Dissemination of bla OXA-58 in Proteus mirabilis isolates from Germany
OXA-48-like carbapenemases in the UK : an analysis of isolates and cases from 2007 to 2014
Rapid direct detection of carbapenemase-producing Enterobacteriaceae in clinical urine samples by MALDI-TOF MS analysis
In vitro activity of the novel echinocandin CD101 at pH 7 and 4 against Candida spp. isolates from patients with vulvovaginal candidiasis
In vitro susceptibility to 19 agents other than β-lactams among third-generation cephalosporin-resistant Enterobacteriaceae recovered on hospital admission
Epidemiology and susceptibility of pathogens from SMART 2011–12 Turkey : evaluation of hospital-acquired versus community-acquired urinary tract infections and ICU- versus non-ICU-associated intra-abdominal infections
In vitro activity of cefepime/zidebactam (WCK 5222) against Gram-negative bacteria
Ceftolozane/tazobactam activity against drug-resistant Enterobacteriaceae and Pseudomonas aeruginosa causing urinary tract and intraabdominal infections in Europe : report from an antimicrobial surveillance programme (2012–15)
In vitro activity of ceftazidime/avibactam against urinary isolates from patients in a Phase 3 clinical trial programme for the treatment of complicated urinary tract infections
Pharmacodynamics of ceftazidime/avibactam against extracellular and intracellular forms of Pseudomonas aeruginosa
Exploring the pharmacodynamic interactions between tedizolid and other orally bioavailable antimicrobials against Staphylococcus aureus and Staphylococcus epidermidis
Polymyxin-resistant, carbapenem-resistant Acinetobacter baumannii is eradicated by a triple combination of agents that lack individual activity
Determining β-lactam exposure threshold to suppress resistance development in Gram-negative bacteria
Pharmacokinetic study of anidulafungin in ICU patients with intra-abdominal candidiasis
Population pharmacokinetics and dosing simulations of ceftazidime in critically ill patients receiving sustained low-efficiency dialysis
Effect of rifampicin and efavirenz on moxifloxacin concentrations when co-administered in patients with drug-susceptible TB
Rapid accumulation of HIV-1 thymidine analogue mutations and phenotypic impact following prolonged viral failure on zidovudine-based first-line ART in sub-Saharan Africa
Changes in bone turnover markers with HIV seroconversion and ART initiation
Antibiotic stability related to temperature variations in elastomeric pumps used for outpatient parenteral antimicrobial therapy (OPAT)
Repurposing an old drug : aztreonam as a new treatment strategy for gonorrhoea
Antimicrobial resistance in uropathogens and appropriateness of empirical treatment : a population-based surveillance study in Indonesia
MIC of amoxicillin/clavulanate according to CLSI and EUCAST : discrepancies and clinical impact in patients with bloodstream infections due to Enterobacteriaceae
Risk factors and impact of Clostridium difficile recurrence on haematology patients
Factors associated with carriage of carbapenem-non-susceptible Enterobacteriaceae in North-Eastern France and outcomes of infected patients
Antimicrobial strategy for severe community-acquired legionnaires’ disease : a multicentre retrospective observational study
Increased prescribing of systemic tetracyclines and isotretinoin for treatment of acne
Surveillance of antimicrobial use in Dutch long-term care facilities
Obtaining antibiotics online from within the UK : a cross-sectional study
High prevalence of the A2058T macrolide resistance-associated mutation in Mycoplasma genitalium strains from the Netherlands
A novel disrupted mcr-1 gene and a lysogenized phage P1-like sequence detected from a large conjugative plasmid, cultured from a human atypical enteropathogenic Escherichia coli (aEPEC) recovered in China
mcr-2 in the IncX4 plasmid pKP37-BE is flanked by directly oriented copies of ISEc69
Serratia marcescens producing SME carbapenemases : an emerging resistance problem in the UK?
Ultradeep sequencing detection of the R263K integrase inhibitor drug resistance mutation
APOL1 variants may induce HIV-associated nephropathy during HIV primary infection
Successful retreatment of a patient with chronic hepatitis C genotype 2k/1b virus with ombitasvir/paritaprevir/ritonavir plus dasabuvir
Antibiotic restriction policy paradoxically increased private drug consumptions outside Taiwan’s National Health Insurance
Comment on : Integrase strand-transfer inhibitor polymorphic and accessory resistance substitutions in patients with acute/recent HIV infection
Integrase strand-transfer inhibitor polymorphic and accessory resistance substitutions in patients with acute/recent HIV infection—authors’ response
Comment on : Efficacy of elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate as treatment for primary or recent HIV infection
Efficacy of elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate as treatment for primary or recent HIV infection—authors’ response